Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration - PDF (俄文)
版权所有 © Consilium Medicum, 2018
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。